Reports suggest that PKIB can promote proliferation and metastasis of NSCLC cells, as well as support malignant transformation of triple-negative breast cancer, promote infiltration of colorectal carcinoma, and support prostate cancer aggressiveness (33, 46–48). This evidence concerns the gene PKIB and colorectal carcinoma.